Our team of Cell and Gene Therapy professionals bring deep technical expertise to help you tackle the unique challenges of our exciting young field.

FOUNDER & CEO
Founded Dark Horse Consulting in 2014. Over 20 years of experience in CMC leadership of cell and gene therapy companies.
COO & MANAGING PARTNER
Seasoned executive with experience leading a wide range of technical, strategic, business and legal functions.
PRINCIPAL
Cross-functional project leader in biopharmaceutical management of international clinical development, regulatory submissions and development strategy.
PRINCIPAL

Twenty years of experience in CMC for C&GT, including viral vectors, plasmids, and cell therapies.

PRINCIPAL

Nineteen years of experience in CMC for cell and gene therapies, including technology transfer, process development, quality by design, manufacturing, regulatory and facility design.

PRINCIPAL
Bioengineer with expertise in cell therapy, gene therapy, and combination products. Lean Six Sigma Black Belt.
PRINCIPAL

Over 25 years of experience in the development and commercialization of advanced therapeutics in multiple geographies, with particular focus on characterization, analytical development/validation, and quality control.

PRACTICE EXPERT, INTELLECTUAL PROPERTY and VICE PRESIDENT, LEGAL AFFAIRS

Intellectual property (IP) expert and registered patent attorney with over 10 years of combined experience in biologics and cell therapy patent prosecution and IP strategy at various stages of product development and commercialization.

PRACTICE EXPERT, QUALITY
Quality and regulatory scientist with 25+ years of experience providing guidance for successful FDA submissions, technology transfers and validation associated with human cellular and tissue based products, biologics, and medical devices.
PRACTICE EXPERT

EU Qualified Person and Practice Expert with 15 years of experience of IMP and commercial manufacture, quality, validation, clinical trials, regulatory submissions, and remediation activitie

SENIOR CONSULTANT
Data-driven engineer and subject matter expert in cell cryopreservation, process optimization, scale-up, and technology transfer of cell therapies and clinical diagnostics.
SENIOR CONSULTANT
Cell and gene therapy scientist with 15 years of experience leading research, preclinical, and process optimization for preclinical and clinical stage development programs in industry and academia.
SENIOR CONSULTANT

Nine+ years of experience in process development, cGMP manufacture, technical writing and project management for leading cell and gene therapy companies and academic labs.

CONSULTANT

Four+ years CDMO experience in gene therapy, focusing on analytical method development, tech transfer and validation.

CONSULTANT
12 years of experience in process development, GMP manufacturing and technology transfer of cell and virally-modified cell therapy products.
CONSULTANT
Brings broad engineering expertise to help DHC clients tackle their device design, instrument development, and process engineering challenges throughout their products’ lifecycles.
CONSULTANT
Over 5 years of gene therapy experience, spanning upstream, downstream and analytical process development. Lean Six Sigma Green Belt.
Rachel, Business Ops Specialist at Dark Horse, smiling
BUSINESS OPERATIONS SPECIALIST

Responsible for maintaining databases and pipeline structure, administering inter-company contracts, acting as point of contact for corporate interactions, and shadowing in business development. Started at Dark Horse as Administration Coordinator to the CEO.  

Jessi Rubbicco, Exec Assistant, smiling
EXECUTIVE ASSISTANT

Responsible for scheduling meetings, travel, onboarding, conferences, and other events as well as providing C-suite support. Previous experience includes five years of research coordination and assistance in the finance sector as well as ~four years as water polo assistant coach at Harvard University. 

We use cookies to help give you the best experience on our website. By continuing you agree to our use of cookies.